Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 945-950

  Pol, Stanislas ^b   Lamorthe, Barbara ^c   Thi, Ngoc Trinh ^c   Thiers, Valérie ^c   Carnot, Françoise ^a   Zylberberg, Hervé ^c   Berthelot, Pierre ^c   Bréchot, Christian ^c   Nalpas, Bertrand ^c  

^a Hopital Laennec   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c NONE

Author keywords

Alcohol; HCV HIV coinfection; Hepatitis C virus; Human immunodeficiency virus

Indexed keywords

ALCOHOL; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032101819     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80341-3     Document Type: Article

References (36)

1. MacDonald JA, Harris S, Waters JA, Thomas HC. Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic antigen display. J Hepatol. 4:1987;337-342.
2. Horvath J, Raffanti SP. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis. 18:1994;339-347.
3. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatits B in asymptomatic homosexual men with antibody to human immunodeficiency virus. Ann Intern Med. 105:1986;382-383.
4. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology. 15:1992;578-583.
5. Mannucci PM, Colombo M, Rizetto M. Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs. Blood. 60:1982;655-658.
6. White GC II, Zeitler KD, Lesesne HR, McMillan CW, Warren MS, Roberts HR, et al. Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests. Blood. 60:1982;1259-1262.
7. Triger DR, Preston FE. Chronic liver disease in haemophiliacs. Br J Haematol. 74:1990;241-245.
8. Andreu J, Sanchez-Quijano A, Gavilan F, Luque F, Abad MA, Soto B, et al. Influence of human immunodeficiency virus type 1 infection on the natural history of chronic parenteral-acquired hepatitis C [abstract]. J Hepatol. 21:1994;95. (Suppl).
9. Soto B, Rodrigo L, Del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, Lissen E. Influence of human immunodeficiency virus type 1 infection on the natural history of chronic parenteral-acquired hepatitis C. A multicenter study on 547 patients [abstract]. J Hepatol. 21:1994;25. (Suppl).
10. Areias J, Lopes I. Influence of HIV infection in chronic hepatitis C in intravenous drug addict [abstract]. Hepatology. 16:1992;195.
11. Quan CM, Krajden M, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis. 17:1993;117-119.
12. Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes M-C, Muyssen A, et al. Prevalence of serological markers of hepatitis C, B and D and histological aspects in intravenous drug users. Gastroenterol Clin Biol. 18:1994;964-968.
13. Center for Disease Control and Prevention: 1993 revised classification system for HIV infection and expended surveillance case definition for AIDS among adolescents and adults MMWR. 41:1992;1-19.
14. Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa I, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 60:1990;167-177.
15. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
16. Pol S, Thiers V, Nousbaum J-B, Legendre C, Berthelot P, Kreis H, et al. The changing prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology. 108:1995;581-583.
17. Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods. 65:1997;9-17.
18. Sherlock S. Classifying chronic hepatitis. Lancet. ii:1989;1168-1170.
19. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
20. Hay CRM, Preston FE, Triger DR, Underwood JCE. Progressive liver disease in haemophilia: an understated problem? Lancet. i:1985;1495-1498.
21. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 97:1989;1559-1561.
22. Ridzon R, Gallagher K, Ciesielski C, Mast EE, Ginsberg MB, RobertsoN BJ, et al. Simultaneous transmissio of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med. 336:1997;919-922.
23. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused effect of coinfection with human immunodeficiency virus. The multicenter hemophilia cohort study. J Acquir Immune Defic Syndr. 6:1993;602-610.
24. Matsuda J, Tsukamoto M, Gohchi K, Saitoh N, Gotoh M. Hepatitis C virus (HCV) RNA and human imunodeficiency virus (HIV) p24 antigen in the cryoglobulin of hemophiliacs with HIV and/or HCV infection. Clin Infect Dis. 18:1994;832-833.
25. Eyster ME, Fried MW, DiBisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to HIV infection and liver disease. Blood. 84:1994;1020-1023.
26. Telfer PT, Brown D, Devereux H, Lee CA, Dusheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol. 88:1994;397-399.
27. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, et al. Hepatitis C virus genotype, tissue HCV antigens, hepatocellular expression of HLA-A, B, C and intercellular adhesion molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatement in patients with chronic hepatitis C. J Clin Invest. 95:1995;2067-2075.
28. Osborne L, Kunkel S, Mabel G. Tumor necrosis factor-alpha and interleukin-1 stimulate the HIV enhancer by activation of the nuclear factor-kB. Proc Natl Acad Sci USA. 86:1989;2336-2341.
29. Levrero M, Balsano C, Natoli G. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2. J Virol. 64:1990;3082-3086.
30. Seto E, Yen TSB, Peterlin BM, Ou JH. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA. 85:1988;8286-8290.
31. Pol S, Debure A, Degott C, Carnot F, Legendre C, Bréchot C, et al. Chronic hepatitis in kidney allograft recipients. Lancet. 335:1990;878-880.
32. Villa E, Rubbiana L, Barchi T, Ferreti I, Grisendi A, De Palma M, et al. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet. ii:1982;1243-1244.
33. Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, et al. Increased serum hepatitis C virus RNA level among alcoholic patients with chronic hepatitis C. Hepatology. 20:1994;1115-1120.
34. Mufti MI, Prabhala R, Moriguchi S, Sipes IG, Watson RR. Functional and numerical alterations induced by ethanol in the cellular immune system. Immunopharmacology. 15:1988;88-94.
35. Pol S, Artru P, Thepot V, Berthelot P, Nalpas B. Improvement of the T4 cells count following alcohol withdrawal in anti-HIV positive alcoholics. AIDS. 10:1996;1293-1294.
36. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 349:1997;825-832.